A slew of major companies are reporting earnings this week. Generic drugmaker Mylan Inc. (MYL) will announce third-quarter earnings on Monday after the bell. Analysts expect earnings to jump 8.20% to $1.19 per share as the company narrowed down on the costs and expenses. Revenue is expected to drop by 2.60% to $2.91 billion due to a decline in existing product sales.
CVS Health Corp. (CVS) is scheduled to post third-quarter earnings on Tuesday before the bell. Analysts predict earnings of $1.71 per share on a revenue of $47.2 billion. The company’s Pharmacy Services business is likely to be the main driver of its growth as the specialty offerings provide opportunities for user base growth.
Drugmaker Eli Lilly and Co. (LLY) is set to post higher earnings on Tuesday as well. Earnings are likely to jump by 28.60% to $1.35 per share and revenue is predicted to rise by 6.90% to $6.05 billion. The company has a history of posting upbeat results along with encouraging outlook in the past. This will likely to continue in this quarter.
Cloud communications platform Twilio Inc. (TWLO) will post Q3 results on Tuesday after the bell. Street consensus says the company will post earnings of $0.02 per share on revenue of $150.45 million. The company’s active customer accounts stand as the driving factor in the growth.
Online coupon service Groupon Inc. (GRPN) is reporting third-quarter results on Wednesday before the bell. Analysts expect earnings of $0.02 per share on revenue of $601.89 million. The total income the company gets from the sale of goods and services are likely to decline for this quarter. There have been rumors circulating that the company is looking for a prospective buyer and has held preliminary talks with more than one potential buyer so far.
The mobile payments services provider Square’s (SQ) Q3 results will be announced on Wednesday after the market closes. Analysts expect earnings of $0.11 per share on revenue of $413.67 million. The company is likely to widen its footprint and improve its service offerings, which could result in higher product development and increased marketing expenses over last year. Despite the bottom line taking a hole, the efforts are likely to yield the desired results in the long-run.
Chipmaker Qualcomm (QCOM) is set to deliver its fourth-quarter results on Wednesday after the market close. Analysts expect earnings to fall by 10.90% to $0.82 per share as the results could be negatively impacted by its dispute with Apple (AAPL) and its contract manufacturers. Revenues are anticipated to drop by 7.20% to $5.53 billion.
Energy drink maker Monster Beverage Corporation (MNST) will report its third-quarter results on Wednesday after the bell. Earnings are predicted to rise by 15% to $0.46 per share and revenue is likely to increase by 8.50% to $986.85 million. Higher sales from the company’s Drinks segment will continue to drive the growth.
Cloud storage company Dropbox’s (DBX) Q3 results will be reported on Thursday after the market closes. Analysts expect earnings of $0.06 per share on revenue of $352.57 million. Paid users growth and per-user revenue are likely to drive the top line higher. As a dozen new product features have been added, this could strengthen its infrastructure and inch closer to the growth.
Entertainment conglomerate Walt Disney Company (DIS) will post Q4 results on Thursday as well. Analysts expect earnings to jump by 24.30% to $1.33 per share and revenue to rise by 7.40% to $13.72 billion. The company will remain benefited from all the major business segments, box office success of new movie releases, a rise in average ticket prices at Parks and Resorts division, and the recovery of ESPN.
As gaming giant Activision Blizzard (ATVI) announces third-quarter results on Thursday, analysts expect earnings to fall 16.70% to $0.50 per share and revenue to drop 12.50% to $1.66 billion. The company will face a decline in the net bookings and in active monthly users as rivals are giving stiff competition.
Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!
Most Popular
Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO
Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training
INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues
Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came
Riding the AI wave, Nvidia looks set to stay on the high-growth path
After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on
